Investor Relations

Stock price graph
     

Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.

HTML file 2012 Interactive Annual Report

Recent Releases

Jul 24, 2014
Doyle, Arora elected; Sterling reelected to Exact Sciences' board of directors

Jul 22, 2014
Exact Sciences Reports Second-Quarter 2014 Financial Results

Jul 16, 2014
Exact Sciences to host second-quarter 2014 results, annual meeting webcasts and calls

View all releases »

Stock Quote

Ticker:
EXAS
Exchange:
NASDAQ
Price:
15.58
Change:
- 0.41
Volume:
954,300
4:00 PM ET on Jul 28, 2014
Delayed at least 20 minutes.
Provided by eSignal.

IR Search